Capstar Tablets (57 mg) (Canada)

This page contains information on Capstar Tablets (57 mg) for veterinary use.
The information provided typically includes the following:
  • Capstar Tablets (57 mg) Indications
  • Warnings and cautions for Capstar Tablets (57 mg)
  • Direction and dosage information for Capstar Tablets (57 mg)

Capstar Tablets (57 mg)

This treatment applies to the following species:
Manufacturer: Novartis

(nitenpyram)

TABLETS FOR DOGS AND CATS

DIN 02243436 (11.4 mg), 02243437 (57 mg)

Introduction

CAPSTAR (nitenpyram) Tablets have been developed for the oral treatment of flea infestations on cats and dogs. The active ingredient, nitenpyram, is a systemic flea adulticide which rapidly and completely eliminates adult fleas taking a blood meal from a treated animal. Nitenpyram interferes with normal nerve transmission in the fleas and leads to the death of these parasites.

Capstar Tablets (57 mg) Indication

CAPSTAR (nitenpyram) Tablets are indicated for the rapid elimination of fleas (Ctenocephalides felis) on dogs, cats, puppies and kittens four weeks of age and older.

Capstar Tablets (57 mg) Dosage And Administration

CAPSTAR Tablets are available in two concentrations of nitenpyram for convenient dosing: 11.4 mg per tablet for small dogs and cats and 57 mg per tablet for large dogs. The minimum recommended dosage is 1 mg of nitenpyram per kg of body weight. The product can be given directly into the mouth, or mixed with the pet’s favorite food according to the following schedule:

WEIGHT OF DOG OR CAT

DOSE (TABLETS)

1 to 11 kg

One small (11.4 mg) tablet per day, until fleas are no longer found on the host.

>11 to 57 kg

One large (57 mg) tablet per day, until fleas are no longer found on the host.

Dogs over 57 kg should receive the appropriate combination of tablets.

Flea detection can be achieved by examining the skin for signs of flea activity by parting the pet’s coat.

It is important to treat all dogs and cats in a household: fleas can reproduce on untreated dogs and cats and allow infestations to persist. Because immature fleas continue to develop into adult fleas for several weeks after the administration of CAPSTAR, repeated treatment may be necessary for optimal control of infestation.

Note: Effective long-term flea control demands an integrated approach. Monthly administration of an insect development inhibitor, such as lufenuron (SENTINEL®, PROGRAM®), will prevent the development of immature stages of the flea’s life cycle.

Safety

CAPSTAR (nitenpyram) has a wide margin of safety in the intended species when used as per label directions. It can be safely administered to dogs and cats, puppies and kittens four weeks of age and older, pregnant or lactating females and breeding male and female dogs and cats.

CAPSTAR (nitenpyram) Tablets have been administered safely to cats and dogs in conjunction with other commonly used veterinary products including anthelmintics, antibiotics, corticosteroids, vaccines and shampoos.

There are no known contraindications to the use of this product in dogs and cats.

Pharmacology

The active ingredient of CAPSTAR, nitenpyram, is a novel molecule belonging to the chemical class of neonicotinoid compounds, which bind with and inhibit insect specific nicotinic acetylcholine receptors; however, it does not inhibit acetylcholinesterase. It interferes with normal nerve transmission and leads to the death of the fleas.

Nitenpyram is very rapidly and almost completely absorbed from the gastrointestinal tract of cats and dogs; feeding does not influence absorption. On average, the maximum blood concentration is reached 1 hour (range: 15 to 90 minutes) after administration in both species, and the elimination half-life is about 3 hours in dogs and 7.5 hours in cats. More than 90% of the active ingredient is eliminated in the urine within one day in dogs and two days in cats, mainly as unchanged nitenpyram.

Nitenpyram starts working rapidly after dosing and kills >98% of the fleas on the pet within 6 hours; all adult fleas are eliminated 24 hours after a single treatment.

Capstar Tablets (57 mg) Caution

Do not administer this product to puppies or kittens less than four weeks of age.

Warning

Keep this, and all drugs, out of the reach of children; if accidentally swallowed, call a physician.

Storage

Do not store above 25°C. Protect from humidity.

Presentation

CAPSTAR Tablets are available in two concentrations of nitenpyram for convenient dosing: 11.4 mg per tablet for small dogs and cats and 57 mg per tablet for large dogs. Each size is offered for sale in aluminum blisters containing six or sixty tablets per package.

Novartis Animal Health Canada Inc., Suite 400, Plaza 3, 2000 Argentia Road, Mississauga, Ontario L5N 1V9

® CAPSTAR is a registered trademark of Novartis AG, Novartis Animal Health Canada Inc., licensed user

© 2009

® Sentinel and Program are registered trademarks of Novartis Animal Health Canada Inc.

NAH/CAP/T/CAN/PI/2

NAC No.: 12310384

NOVARTIS ANIMAL HEALTH CANADA INC.
2000 ARGENTIA RD., SUITE 400, PLAZA 3, MISSISSAUGA, ON, L5N 1V9
Telephone:   800-387-6325
Order Desk:   800-387-6325
Fax:   905-567-0221
Fax Orders:   800-827-5782
Website:   www.ah.novartis.ca
Email:   ah.questions@novartis.com
Every effort has been made to ensure the accuracy of the Capstar Tablets (57 mg) information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web5)